1. 欧盟罕见病用药审评审批分析及其对我国的启示.
- Author
-
吴文文, 季 兴, 倪明明, 王珊珊, 李 曼, 刘卿青, and 许 静
- Subjects
DRUG approval ,RARE diseases ,PHARMACEUTICAL policy ,DRUG development ,DRUG marketing - Abstract
Copyright of Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi is the property of Evaluation & Analysis of Drug-Use in Hospitals of China Editorial Board and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF